Abstract
In rats the antinociceptive actions of morphine (injected intraventricularly) or of [Met5]enkephalin-Arg6-Phe7 (YGGFMRF) (injected intrathecally) were attenuated by a pretreatment with 10 microliter of artificial cerebral spinal fluid containing 1 microM captopril/1 microM bestatin/2.5 microM Phe-Met-Arg-Phe-NH2 (FMRF-NH2) given 5 min earlier by the same route. A high molecular weight form of FMRF-NH2 purified from bovine brain attenuated the antinociceptive action of YGGFMRF. IgG, prepared from a specific FMRF-NH2 antiserum, elicited a moderate antinociception reversible by naloxone; in contrast, IgG prepared from control serum failed to change tail-flick latencies. In rats receiving morphine every 2 hr and anti-FMRF-NH2 IgG every 4 hr, the antinociceptive action was still evident after eight successive injections; in rats receiving only morphine, the antinociceptive action had disappeared after six successive injections. Morphine (1 microM) added to the perfusion fluid of the subarachnoidal spaces of rat spinal cord releases FMRF-NH2-like peptides in the perfusate.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Faris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science. 1983 Jan 21;219(4582):310–312. doi: 10.1126/science.6294831. [DOI] [PubMed] [Google Scholar]
- Gayton R. J. Mammalian neuronal actions of FMRFamide and the structurally related opioid Met-enkephalin-Arg6-Phe7. Nature. 1982 Jul 15;298(5871):275–276. doi: 10.1038/298275a0. [DOI] [PubMed] [Google Scholar]
- Greenberg M. J., Painter S. D., Doble K. E., Nagle G. T., Price D. A., Lehman H. K. The molluscan neurosecretory peptide FMRFamide: comparative pharmacology and relationship to the enkephalins. Fed Proc. 1983 Jan;42(1):82–86. [PubMed] [Google Scholar]
- Han J. S., Li S. J., Tang J. Tolerance to electroacupuncture and its cross tolerance to morphine. Neuropharmacology. 1981 Jun;20(6):593–596. doi: 10.1016/0028-3908(81)90213-6. [DOI] [PubMed] [Google Scholar]
- Jessell T. M., Iversen L. L. Opiate analgesics inhibit substance P release from rat trigeminal nucleus. Nature. 1977 Aug 11;268(5620):549–551. doi: 10.1038/268549a0. [DOI] [PubMed] [Google Scholar]
- Nagle G. T. The molluscan cardioactive neuropeptide FMRFamide: subcellular localization in bivalve ganglia. J Neurobiol. 1981 Nov;12(6):599–611. doi: 10.1002/neu.480120608. [DOI] [PubMed] [Google Scholar]
- Nagle G. T. The molluscan neuropeptide FMRFamide: calcium-dependent release and blood levels in Macrocallista (Bivalvia). Life Sci. 1982 Mar 8;30(10):803–807. doi: 10.1016/0024-3205(82)90592-6. [DOI] [PubMed] [Google Scholar]
- Price D. A., Greenberg M. J. Structure of a molluscan cardioexcitatory neuropeptide. Science. 1977 Aug 12;197(4304):670–671. doi: 10.1126/science.877582. [DOI] [PubMed] [Google Scholar]
- Tang J., Chou J., Yang H. Y., Costa E. The effect of peptidase inhibitors on the release of Met5-Enk-Arg6-Phe7 (YGGFMRF) and Met5-enkephalin (YGGFM) from spinal cord induced by substance P in vivo. Life Sci. 1983;33 (Suppl 1):121–124. doi: 10.1016/0024-3205(83)90459-9. [DOI] [PubMed] [Google Scholar]
- Weber E., Evans C. J., Samuelsson S. J., Barchas J. D. Novel peptide neuronal system in rat brain and pituitary. Science. 1981 Dec 11;214(4526):1248–1251. doi: 10.1126/science.7029714. [DOI] [PubMed] [Google Scholar]
- Williams R. G., Dockray G. J. Immunohistochemical studies of FMRF-amide-like immunoreactivity in rat brain. Brain Res. 1983 Oct 16;276(2):213–229. doi: 10.1016/0006-8993(83)90728-x. [DOI] [PubMed] [Google Scholar]
- Yaksh T. L., Abay E. O., 2nd, Go V. L. Studies on the location and release of cholecystokinin and vasoactive intestinal peptide in rat and cat spinal cord. Brain Res. 1982 Jun 24;242(2):279–290. doi: 10.1016/0006-8993(82)90311-0. [DOI] [PubMed] [Google Scholar]